A new trading day began on Monday, with Legend Biotech Corp ADR (NASDAQ: LEGN) stock price up 4.27% from the previous day of trading, before settling in for the closing price of $40.94. LEGN’s price has ranged from $36.92 to $70.13 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 50.60% over the last five years. Meanwhile, its annual earnings per share averaged 46.57%. With a float of $181.93 million, this company’s outstanding shares have now reached $183.45 million.
The firm has a total of 1826 workers. Let’s measure their productivity. In terms of profitability, gross margin is 60.75%, operating margin of -53.92%, and the pretax margin is -66.41%.
Legend Biotech Corp ADR (LEGN) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Legend Biotech Corp ADR is 0.83%, while institutional ownership is 49.79%. The most recent insider transaction that took place on Sep 25 ’24, was worth 66,326. Before that another transaction happened on Sep 20 ’24, when Company’s Officer proposed sale 90,060 for $48.91, making the entire transaction worth $4,405,003.
Legend Biotech Corp ADR (LEGN) Recent Fiscal highlights
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.8 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.29 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 46.57% per share during the next fiscal year.
Legend Biotech Corp ADR (NASDAQ: LEGN) Trading Performance Indicators
Here are Legend Biotech Corp ADR’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.90. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 15.06.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.91, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -0.39 in one year’s time.
Technical Analysis of Legend Biotech Corp ADR (LEGN)
Analysing the last 5-days average volume posted by the [Legend Biotech Corp ADR, LEGN], we can find that recorded value of 1.8 million was better than the volume posted last year of 1.12 million. As of the previous 9 days, the stock’s Stochastic %D was 76.46%. Additionally, its Average True Range was 2.21.
During the past 100 days, Legend Biotech Corp ADR’s (LEGN) raw stochastic average was set at 24.09%, which indicates a significant decrease from 67.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 50.93% in the past 14 days, which was higher than the 49.95% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $44.75, while its 200-day Moving Average is $50.63. Now, the first resistance to watch is $43.60. This is followed by the second major resistance level at $44.51. The third major resistance level sits at $45.76. If the price goes on to break the first support level at $41.44, it is likely to go to the next support level at $40.19. Now, if the price goes above the second support level, the third support stands at $39.28.
Legend Biotech Corp ADR (NASDAQ: LEGN) Key Stats
With a market capitalization of 7.83 billion, the company has a total of 182,305K Shares Outstanding. Currently, annual sales are 285,140 K while annual income is -518,250 K. The company’s previous quarter sales were 160,210 K while its latest quarter income was -125,320 K.
